期刊文献+

秀丽隐杆线虫在神经退行性疾病致病机制研究及中药干预作用中的应用 被引量:4

Study on the Application of Caenorhabditis elegans in the Pathogenesis of Neurodegenerative Diseases and the Intervention Effect of Traditional Chinese Medicine
原文传递
导出
摘要 缺乏合适动物平台是神经退行性疾病研究受到阻碍的主要因素之一。秀丽隐杆线虫因其独特的结构和功能已成为生物学不同领域中常用的模式生物。线虫是第一个拥有完整基因组测序的多细胞生物,且与人类基因之间具有高度的保守性。它神经系统结构简单,但其神经元功能和神经递质与哺乳动物具有同源性,是研究神经退行性疾病的良好在体模型。临床治疗神经退行性疾病仍缺乏有效药物,许多现有药物疗效不佳且存在一定的不良反应,传统中药在这方面有着不可忽视的优势。将线虫模型用于神经退行性疾病研究及中药干预作用中具有重要意义。 The lack of appropriate animal platform is the main factor that hinder the study of neurodegenerative diseases.Because of the unique structure and function of Caenorhabditis elegans( C. elegans),it has become a model organism in different fields of biology. C. elegans was the first multicellular organism that had the complete genome sequencing and with a high degree of conservation compared with human genes. Despite of simple nervous system,it was considered as a good model in vivo for neurodegenerative diseases due to the homology of neurons function and neurotransmitters between C. elegans and mammals. Lack of effective drugs is still a problem in the treatment of neurodegenerative diseases. Many existing drugs showed poor curative effect and certain adverse reactions,while the advantage of traditional Chinese medicine can not be ignored. It would be of great importance of the application of C. elegans model in the study of neurodegenerative diseases and the intervention effect of traditional Chinese medicine.
出处 《上海中医药大学学报》 CAS 2016年第4期92-97,共6页 Academic Journal of Shanghai University of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81202981) 江苏省中药资源产业化过程协同创新中心开放项目(ZDXM-2-7)
关键词 秀丽隐杆线虫 神经退行性疾病 中药 应用 前景 Caenorhabditis elegans neurodegenerative diseases Chinese medicine application prospect
  • 相关文献

参考文献38

  • 1Brenner S. The genetics of Caenorhabditis elegans [J]. Genetics, 1974, 77(1) : 71-94.
  • 2Fay D. Genetic mapping and manipulation: chapter 1-Introduction and basics[J]. Wormbook, 2006: 1-12.
  • 3Wolff S, Ma H, Burch D, et al. SMK- 1, an essential regulator of DAF- 16-mediated longevity[J]. Cell, 2006, 124 (5) : 1039-1053.
  • 4Gidalevitz T, Wang N, Deravaj T, et al. Natural genetic variationdetermines susceptibility to aggregation or toxicity in a C. elegans model for polyglutamine disease[J]. BMC Biology, 2013, 11 : 100- 111.
  • 5Harris TW, Chen N, Cunningham F, et al. WormBase: A multi- species resource for nematode biology and genomics [J]. Nucleic Acids Res, 2004, 32(22) : 411-417.
  • 6Bettens K, Sleegers K, Broeckhoven CV. Genetic insights in Alzheimer' s disease [J]. Lancet Neurol, 2013, 12 ( 1 ) : 92-104.
  • 7Hassan WM, Dostal V, Huemann BN, et al. Identifying Ai3- specific pathogenic mechanisms using a nematode model of Alzheimer' s disease [J]. Neurobiol Aging, 2015, 36 ( 2 ) : 857-866.
  • 8Galindo MF, Ikuta I, Zhu X, et al. Mitochondrial biology in Alzheimer' s disease pathogenesis [J]. J Neurochem, 2010, 114 (4) : 933-945.
  • 9Regitz C, Wenzel U. Amyloid-beta (Aβ1-42)-induced paralysis in Caenorhabditis elegans is reduced by restricted cholesterol supply [J]. Neurosci Lett, 2014, 576: 93-96.
  • 10Cook CN, Murray ME, Petrucelli L. Understanding biomarkers of neurodegeneration: Novel approaches to detecting tau pathology [J]. Nat Med, 2015, 21(3): 219-220.

二级参考文献65

  • 1Dauer W, Przedborski, S. Parkinson's disease : mechanisms and models [ J ]. Neuron,2003,39 (6) : 889-909.
  • 2Henchcliffe C, Beal MF. Mitochondrial biology and oxida- tive stress in Parkinson disease pathogenesis[J]. Nat Clin Pract Neurol,2008,4( 11 ) :600-609.
  • 3Thomas B,Beal ME Parkinson's disease[J]. Hum Mol- Genet,2007,16 (R2) : R183-R194.
  • 4Banerjee R, Starkov AA, Beal MF, et al. Mitochondrial dys- function in the limelight of Parkinson's disease pathogene- sis [ J ]. Biochim Biophys Acta, 2009,1792 (7) : 651-663.
  • 5Ebadi M,Sharma SK. Peroxynitrite and mitochondrial dys- function in the pathogenesis of Parkinson' s disease [ J ]. Antioxid Redox Signal ,2003,5 (3) :319-335.
  • 6Mandemakers W, Morais VA, De SB. A cell biological per- spective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases [ J ]. J Cell Sci, 2007,120(pt10) : 1707-1716.
  • 7Link CD. Transgenic invertebrate models of age-associated neurodegenerative diseases [ J ]. Mech Ageing Dev, 2001, 122(14) :1639-1649.
  • 8Nass R,Blakely RD. The Caenorhabditis elegans dopamin- ergic system:opportunities for insights into dopamine trans- port and neurodegeneration[ J]. Annu Rev Pharmacol Toxi- col ,2003,43:521-544.
  • 9Yu MS, Ho YS, So KF,et al. Cytoprotective effects of Lyci- um barbarum against reducing stress on endoplasmic retic- ulum[J]. Int J Mol Med,2006,17( 6) :1157-1161.
  • 10Ho YS, Yu MS, Lai CS, et al. Characterizing the neuro- protective effects of alkaline extract of Lycium barbarum on β-amyloid peptide neurotoxicity [ J ]. Brain research, 2007,16 : 123-134.

共引文献13

同被引文献58

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部